AIDS group bans Merck & Co reps from its US clinics
This article was originally published in Scrip
Executive Summary
The AIDS Healthcare Foundation (AHF), which operates clinics around the world including more than a dozen in the US, has ramped up its efforts to embarrass Merck & Co over US pricing for the first HIV integrase inhibitor, Isentress (raltegravir), by banning Merck sales reps from its US facilities.